Skip to content

Maternal and Fetal Outcomes in Elective vs Emergency Cesarean Section

Maternal and Fetal Outcomes in Elective and Emergency Cesarean Section in Women's Health Hospital

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07651241
Enrollment
210
Registered
2026-06-16
Start date
2026-07-01
Completion date
2027-09-01
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal and Fetal Outcomes in Elective vs Emergency Cesarean Section

Brief summary

Cesarean section (CS) rates have increased substantially worldwide and in Egypt, where they now account for the majority of deliveries. Maternal and neonatal outcomes may differ between elective and emergency CS. Emergency cesarean sections are generally associated with higher maternal morbidity, including increased risks of postpartum hemorrhage, infection, blood transfusion, longer operative time, and prolonged hospital stay. Neonatal outcomes following emergency CS may also be less favorable, with higher rates of low Apgar scores, respiratory distress, and NICU admission. However, findings remain inconsistent across studies, highlighting the need for further prospective research to comprehensively compare maternal and fetal outcomes between elective and emergency cesarean deliveries.

Interventions

PROCEDUREemergency cesarean section

emergency cesarean section

PROCEDUREelective cesarean section

elective cesarean section

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* 1- Pregnant women undergoing cesarean section 2- Singleton pregnancy 3- Gestational age ≥ 28 weeks 4- Age 18-45 years

Exclusion criteria

* 1- Multiple pregnancy 2- Known fetal anomalies 3- Intrauterine fetal demise before cesarean section 4- Severe maternal comorbidities (e.g., cardiac disease, renal failure) 5- Rupture uterus 6- patients with placenta previa or accreta spectrum

Design outcomes

Primary

MeasureTime frame
• Maternal morbidity composite outcome • Neonatal morbidity composite outcomeFrom cesarean delivery until hospital discharge (up to 7 days postpartum).

Secondary

MeasureTime frame
Length of stayFrom cesarean delivery until maternal hospital discharge (days), up to 7 days postpartum.
Operative timeAssessed during cesarean section, from skin incision to skin closure (minutes).
Infection rateFrom cesarean delivery through 6 weeks postpartum.
Effect of confounding factors on neonatal outcomes (gestational age at delivery, type of anaesthesia)Assessed at birth and during neonatal hospitalization, up to 28 days after birth.
Effect of confounding factors on maternal outcomes (BMI)BMI assessed at admission for delivery; association with maternal outcomes evaluated from cesarean delivery through hospital discharge (up to 7 days postpartum).

Contacts

CONTACTAlwany Elsenousy Eldreemy Elkasse, professor
alwany.elsenousy@med.aun.edu.eg+2001225005036
CONTACTMohamed Bahaa Mohamed Ahmed, lecturer
m.bahaa@med.aun.edu.eg+200 10 22422960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026